Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veramyst and Olopatadine in Seasonal Allergic Rhinitis
NCT01007253Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Nov 2009
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone, olopatadine in seasonal allergic rhinitis (SAR), sponsored by University of Chicago. Started Nov 2009; status: completed.
02
Drugs
fluticasoneolopatadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01007253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007253.